Video Latest - ecancer

ASH 2016 highlights: breaking new ground in haematology

Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy

6 Dec 2016

TCA cycle inhibition by CPI-613 increases chemo sensitivity in older AML patients

Dr Timothy Pardee - Wake Forest Baptist Medical Center, Winston-Salem, USA

6 Dec 2016

Azacitidine plus nivolumab against acute myeloid leukaemia

Prof Naval Daver - MD Anderson Cancer Center, Houston, USA

6 Dec 2016

Highlights in myeloid leukaemia research from ASH 2016

Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy

5 Dec 2016

Clinical updates for guadecitabine and vorinostat

Dr Guillermo Montalbán Bravo - MD Anderson Cancer Center, Houston, USA

5 Dec 2016

Pracinostat and azacitidine for elderly AML

Prof Guillermo Garcia-Manero - MD Anderson Cancer Center, Houston, USA

5 Dec 2016

Ibrutinib in CLL: RESONATE and resistance

Dr Jennifer Woyach - The Ohio State University Medical Center, Columbus, USA

4 Dec 2016

Novel antibody boosts responses in newly diagnosed AML

Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA

3 Dec 2016

Vadastuximab talirine in combination for newly diagnosed AML

Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA

3 Dec 2016

A new spin on leukaemia therapy

Prof Armand Keating - University of Toronto, Toronto, Canada

3 Dec 2016

CPX-351 after stem cell transplant for elderly patients with AML

Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA

3 Dec 2016

Radiotherapy or surgery for oral cavity tumours?

Dr Nancy Lee - Memorial Sloan Kettering Cancer Center, New York, USA

24 Nov 2016

Video